A detailed history of Washington Trust Advisors, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 96,565 shares of BDX stock, worth $21.6 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
96,565
Previous 96,409 0.16%
Holding current value
$21.6 Million
Previous $22.5 Million 3.33%
% of portfolio
2.06%
Previous 2.13%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$221.47 - $242.41 $34,549 - $37,815
156 Added 0.16%
96,565 $23.3 Million
Q2 2024

Jul 25, 2024

BUY
$225.07 - $246.17 $14,179 - $15,508
63 Added 0.07%
96,409 $22.5 Million
Q1 2024

May 07, 2024

BUY
$233.45 - $247.73 $26,146 - $27,745
112 Added 0.12%
96,346 $23.8 Million
Q4 2023

Jan 18, 2024

SELL
$232.24 - $267.23 $69,904 - $80,436
-301 Reduced 0.31%
96,234 $23.5 Million
Q3 2023

Oct 18, 2023

BUY
$254.9 - $283.59 $19,117 - $21,269
75 Added 0.08%
96,535 $25 Million
Q2 2023

Jul 27, 2023

BUY
$238.39 - $265.32 $127,777 - $142,211
536 Added 0.56%
96,460 $25.5 Million
Q4 2022

Feb 08, 2023

BUY
$218.29 - $256.91 $2,182 - $2,569
10 Added 0.01%
95,924 $24.4 Million
Q3 2022

Oct 14, 2022

SELL
$51.03 - $264.23 $11,532 - $59,715
-226 Reduced 0.24%
95,914 $21.4 Million
Q2 2022

Jul 25, 2022

BUY
$234.74 - $275.42 $52,816 - $61,969
225 Added 0.23%
96,140 $23.7 Million
Q1 2022

May 05, 2022

BUY
$243.64 - $270.48 $1,949 - $2,163
8 Added 0.01%
95,915 $25.5 Million
Q4 2021

Feb 11, 2022

BUY
$230.08 - $250.94 $22.1 Million - $24.1 Million
95,907 New
95,907 $24.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Washington Trust Advisors, Inc. Portfolio

Follow Washington Trust Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Advisors, Inc. with notifications on news.